Atropine

Active ingredient description

Atropine is an antimuscarinic agent which competitively antagonises acetylcholine at postganglionic nerve endings, thus affecting receptors if the exocrine glands, smooth muscle, cardiac muscle and the central nervous system.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

A03BA01

Atropine

A Alimentary tract and metabolism → A03 Drugs for functional gastrointestinal disorders → A03B BELLADONNA AND DERIVATIVES, PLAIN → A03BA Belladonna alkaloids, tertiary amines

Discover more medicines within A03BA01

S01FA01

Atropine

S Sensory organs → S01 Ophthalmologicals → S01F Mydriatics and cycloplegics → S01FA Anticholinergics

Discover more medicines within S01FA01

Medicines

Atropine is the active ingredient of these drugs:

ATROFARMA

Brazil

ATROPEN

United States

ATROPION

Brazil

ATROPT

Australia

ATROSOL

Hong Kong Singapore

BELLAPAN

Poland

HYTROPIN

Brazil

ISOPTO ATROPINE

Canada United States

PASMODEX

Brazil

Atropine is also found within below combination drugs:

BEAMOTIL , BELLERGOT , CELIDIN , DHAMOTIL , DIAMOTIL , INEUROPE , LOFENOXAL , LOMOTIL , MYDRICAINE , REASEC , SUN-DIANOX , SYNCOMIL

Product monographs

Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):

ATROPINE Solution for injection

Summary of product characteristics (SPC)

UK

ATROPINE Tablet

Summary of product characteristics (SPC)

UK

ISOPTO ATROPINE Ophthalmic solution

Structured product labeling (SPL/PLR)

US

ATROPINE Eye drops

Summary of product characteristics (SPC)

UK